Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
10.3724/abbs.2024150 Summary Keywords atherosclerosis, biomarkers, cardiometabolic disease, endothelial dysfunction, GLP-1RA, macrovascular complications, oxidized LDL (oxLDL), type 2 diabetes Citation Al-Taweel R and Malki A (2026) Role of glucagon-like peptide-1 receptor agonists in type 2 diabetes-associated atherosclerosis: from vascular mechanism to omics-based biomarkers and imaging
1x Serum
In this preclinical study, rat offspring were exposed to prolonged intrauterine ischemia in utero
These are laboratory research observations only, are not established human or veterinary effects, and no combined effect is claimed
Support WBUR Boston's Morning Newsletter Why Blue Cross Blue Shield is rolling back coverage of GLP-1 weight loss drugs in Massachusetts Editor's Note: This is an excerpt from WBUR's daily morning newsletter, WBUR Today
October 1, 2022
US$ 28.14
US$ 29.81
US$ 21.93
US$ 29.33
